SCLT1

SCLT1 is a centriole distal appendage protein essential for ciliogenesis; loss of Sclt1 in mice reduces cilia number in kidney tubules and activates ERK, STAT3, PKA, and SMAD signaling pathways, resulting in cystic kidney disease that is rescued by STAT3 inhibition with pyrimethamine (PMID:28486600). SCLT1 localizes to the distal appendage of the photoreceptor basal body, consistent with a conserved role at sensory cilia (PMID:30425282). SCLT1 mRNA is post-transcriptionally stabilized by METTL1/WDR4-mediated internal m7G methylation, and in non-small cell lung cancer cells SCLT1 activates NF-κB signaling to promote gefitinib resistance (PMID:40857569).

1. 2017 High

   The central question of SCLT1's physiological function was answered: it is a centriole distal appendage protein required for ciliogenesis, and its loss causes cystic kidney disease through hyperactivation of ERK, STAT3, PKA, and SMAD signaling — establishing SCLT1 as a bona fide ciliopathy gene.

   Evidence Sclt1 knockout mouse with immunofluorescence, western blot pathway analysis, and pharmacological rescue of cystic phenotype by STAT3 inhibition

   PMID:28486600

   Open questions at the time

   • The molecular mechanism by which SCLT1 is recruited to distal appendages is unknown
   • Whether SCLT1 loss causes ciliopathy phenotypes in tissues beyond the kidney was not systematically assessed
   • How loss of cilia leads to simultaneous activation of four distinct signaling pathways is not resolved
2. 2018 Medium

   SCLT1's localization at ciliary distal appendages was extended to photoreceptor sensory neurons, broadening its relevance to retinal cilia biology.

   Evidence Immunohistochemistry of mouse retinal tissue showing basal body distal appendage localization

   PMID:30425282

   Open questions at the time

   • Single immunolocalization study from one lab without functional perturbation in retina
   • Whether SCLT1 loss causes retinal degeneration or visual defects has not been tested
   • Interaction partners at the photoreceptor basal body are not identified
3. 2025 Medium

   A previously unrecognized layer of SCLT1 regulation was revealed: METTL1/WDR4-dependent m7G methylation stabilizes SCLT1 mRNA, and in NSCLC this stabilization drives NF-κB activation and gefitinib resistance — connecting an epitranscriptomic mechanism to SCLT1 expression control.

   Evidence m7G MeRIP-seq and RNA-seq target identification; METTL1/WDR4 knockdown and catalytic mutant rescue; functional drug resistance assays in cell lines and xenograft models

   PMID:40857569

   Open questions at the time

   • Single-lab finding; independent replication and identification of the precise m7G site(s) on SCLT1 mRNA are needed
   • How SCLT1 protein activates NF-κB signaling mechanistically is undefined
   • Whether m7G-dependent regulation of SCLT1 mRNA affects ciliary phenotypes in non-cancer contexts is unknown

• Key unresolved questions include how SCLT1 is structurally integrated into the distal appendage complex, which direct binding partners mediate its ciliogenesis function, and whether its NF-κB-activating role in cancer is mechanistically related to its ciliary function.
• No structural or biochemical reconstitution of SCLT1 within the distal appendage
• Direct physical interactors at the centriole are not identified in the primary literature
• Relationship between ciliary and NF-κB signaling roles of SCLT1 is completely unexplored